You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Integrase inhibitor Raltegravir

Showing 1 - 25 of 7,627
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HTLV-I Infection Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Raltegravir)

Completed
  • HTLV-I Infection
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

Completed
Has Results
  • HIV
  • Switch to Maraviroc + Raltegravir or Dolutegravir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Oct 5, 2021

HIV Trial in United States (Raltegravir (MK-0518), Placebo)

Completed
Has Results
  • HIV Infections
  • Raltegravir (MK-0518)
  • Placebo
  • Birmingham, Alabama
  • +19 more
Nov 2, 2021

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Birmingham, Alabama
  • +180 more
Mar 14, 2022

HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

Recruiting
  • HIV/AIDS
  • Antwerp, Belgium
  • +47 more
Jan 9, 2023

HIV-1 Infection Trial in Montpellier (HIV DNA)

Completed
  • HIV-1 Infection
  • HIV DNA
  • Montpellier, France
    University hospital Montpellier
Jul 5, 2021

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

Aging-related Inflammation in HIV-infected Patients Trial in Badalona (Raltegravir, PI-based regimen, Atorvastatin)

Completed
Has Results
  • Aging-related Inflammation in HIV-infected Patients
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Oct 7, 2020

HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

Recruiting
  • HIV I Infection
  • Adiposity
  • Frequently sampled glucose tolerance testing
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 15, 2022

HIV Trial in Worldwide (Raltegravir poloxamer film coated tablet, Raltegravir chewable tablet, Raltegravir oral granules for

Completed
Has Results
  • HIV Infections
  • Raltegravir poloxamer film coated tablet
  • +2 more
  • Alhambra, California
  • +41 more
Oct 29, 2021

HIV Trial in Paris (Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine)

Not yet recruiting
  • HIV Infections
  • Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine
  • Paris, Ile De France, France
    Christine Katlama
Jul 26, 2022

Hiv, Weight Gain Trial in Toronto (DOR/3TC/TDF)

Enrolling by invitation
  • Hiv
  • Weight Gain
  • Toronto, Ontario, Canada
    University Health Network
May 17, 2022

HIV Trial in Hangzhou, Beijing, Shanghai (Oral CAB, CAB LA)

Completed
Has Results
  • HIV Infections
  • Oral CAB
  • CAB LA
  • Hangzhou, Zhejiang, China
  • +2 more
May 12, 2021

HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

Recruiting
  • HIV I Infection
  • +2 more
  • Doravirine 100 Mg
  • Los Angeles, California
  • +1 more
Nov 1, 2022

HIV Infection Trial in Worldwide (DTG +DRV/r, SOC)

Completed
  • HIV Infection
  • Buenos Aires, Argentina
  • +30 more
Mar 25, 2021

Human Immunodeficiency Virus Trial in Oakland Park (Symtuza)

Terminated
  • Human Immunodeficiency Virus
  • Oakland Park, Florida
    Midland Research Group, Inc
Dec 3, 2021

Intensive Viral Dynamics Substudy of A5248

Completed
  • HIV Infections
  • Treatment Naive
    • Aurora, Colorado
    • +5 more
    Oct 28, 2021

    HIV-1 Infection Trial in France (Samplings)

    Recruiting
    • HIV-1 Infection
    • Samplings
    • Clamart, France
    • +6 more
    Jan 4, 2022

    HIV Trial in Brighton, London (Combination Antiretroviral Therapy (cART), Raltegravir, Vorinostat)

    Active, not recruiting
    Has Results
    • HIV
    • Combination Antiretroviral Therapy (cART)
    • +4 more
    • Brighton, United Kingdom
    • +5 more
    Aug 24, 2021

    HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)

    Completed
    Has Results
    • HIV
    • Acute HIV Infection
    • Dolutegravir 50 mg
    • +2 more
    • Chapel Hill, North Carolina
    • +1 more
    Oct 22, 2021

    HIV Trial in Worldwide (GSK1265744 Tablets, Injectable GSK1265744, Placebo for GSK1265744 Tablets)

    Completed
    Has Results
    • HIV Infections
    • GSK1265744 Tablets
    • +3 more
    • Los Angeles, California
    • +7 more
    Oct 14, 2021

    Bictegravir in the Elderly Living With HIV (BICEP)

    Active, not recruiting
    • HIV-1-infection
    • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
    • Buffalo, New York
      Evergreen Health
    Oct 28, 2022

    HIV-1 Infection Trial in Worldwide (Lopinavir/ritonavir, Raltegravir, Emtricitabine/tenofovir disoproxil fumarate)

    Completed
    Has Results
    • HIV-1 Infection
    • Rio de Janeiro, Brazil
    • +15 more
    Aug 3, 2021

    Effect on HIV Medications on EPC Cells

    Completed
    • AIDS
    • Washington, District of Columbia
      The GW Medical Faculty Associates
    Mar 21, 2022

    Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.

    Completed
    Has Results
    • Integrase Inhibitors, HIV; HIV PROTEASE INHIB
    • Barcelona, Spain
      Hospital Clinic
    Aug 29, 2019